Objective: To compare the prognostic factors and outcomes after hepatic resection among patients with hepatitis B virus (HBV)-positive, hepatitis C virus (HCV)-positive, and negative for hepatitis B surface antigen and hepatitis C antibody, so-called "NBNC"-hepatocellular carcinoma (HCC) using the data from a nationwide survey. Background: The incidence of NBNC-HCC is rapidly increasing in Japan. Methods: A total of 11,950 patients with HBV-HCC (n = 2194), HCV-HCC (n = 7018), or NBNC-HCC (n = 2738) who underwent a curative hepatic resection were enrolled in this study. The clinicopathological features were compared among the groups. The significant prognostic variables determined by univariate analysis were subjected to a multivariate analysis using a Cox proportional hazard regression model. Results: Liver function in the HCV-HCC group was significantly worse than that in the HBV-HCC and NBNC-HCC groups. The NBNC-HCC group had significantly more advanced HCC than the HCV-HCC group. The 5-year overall survival rates after hepatectomy in the HBV-HCC, HCV-HCC, and NBNC-HCC groups were 65%, 59%, and 68%, respectively. The 5-year recurrencefree survival (RFS) rates in these 3 groups were 41%, 31%, and 47%, respectively. Stratifying the RFS rates according to the TNM stage showed that the NBNC-HCC group had a significantly better prognosis than the HBV-HCC group in stages II, III, and IVA, and a significantly better prognosis than the HCV-HCC group in stages I and II. Multivariate analysis revealed a significantly better RFS rate in the NBNC-HCC group.
T he most prominent etiological factors associated with hepatocellular carcinoma (HCC) worldwide include chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), and chronic alcohol consumption. Although HCV-related HCC is responsible for the greatest proportion of HCC patients in Japan, 1,2 the proportion of HCC cases negative for hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCVAb), so-called "NBNC-HCC," is rapidly increasing. [3] [4] [5] Many studies have compared the clinicopathological characteristics and prognosis after hepatic resection among patients with different background liver diseases, most of which compared HBV-HCC and HCV-HCC, and the results have been controversial. [6] [7] [8] Both HBV and HCV infections are hepatotrophic viral infections; however, there are significant differences between the molecular carcinogenic mechanisms of these 2 viruses. 9 In addition, several recent studies have compared the surgical outcomes between patients with NBNC-HCC and those with viral-related HCC (HBV-HCC and/or HCV-HCC), with inconsistent results, possibly owing to differences in demographic characteristics and tumor factors, and an insufficient number of patients in the cohorts. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The exact background or molecular mechanisms underlying the sharp increase in the incidence of NBNC-HCC remain unclear; however, nonalcoholic steatohepatitis (NASH) and metabolic syndrome are suggested as important risk factors. 5, 22 Differences in pathogenic mechanisms during hepatocarcinogenesis associated with the underlying chronic liver damage may explain the differences in the clinicopathological features and surgical outcomes observed in HCC patients who underwent hepatic resection. Characterizing the HCC based on the aspects of the background chronic liver damage may provide important insight into novel strategies for the prevention and treatment of the progression and recurrence of HCC.
The Liver Cancer Study Group of Japan (LCSGJ) has prospectively collected data on patients with HCC in Japan using biannual nationwide surveys since 1965. First, physicians in the participatingprognostic factors and outcomes associated with 3 types of treatments in 4741 patients with NBNC-HCC and showed that "hepatic resection" offers a significant prognostic advantage over radiofrequency ablation and transcatheter arterial chemoembolization. 23 Therefore, this study compared the clinicopathological characteristics and prognosis after hepatic resection between the patients with NBNC-HCC and those with viral-related HCC based on data from the same nationwide follow-up survey conducted by the LCSGJ.
PATIENTS AND METHODS
A total of 62,321 patients with primary liver cancer were prospectively registered biannually from January 2000 to December 2005 by the LCSGJ, as reported previously. 23 This included 18,309 patients who underwent hepatic resection as the initial treatment, and 15,390 patients of these were histologically diagnosed with HCC in the resected specimens at each institution. Patients without data for hepatitis viral infection status of HBsAg and HCVAb were excluded. In addition, 309 patients positive for both HBsAg and HCVAb were excluded. Additional exclusions included extrahepatic metastasis, Child-Pugh C, and a noncurative hepatectomy. The study also excluded the 230 patients lacking outcome data. Finally, 11,950 HCC patients were included in this cohort study and were classified according to hepatitis virus infection status into HBV-HCC group (n = 2194, 18.4%), HCV-HCC group (n = 7018, 58.7%), and NBNC-HCC group (n = 2738, 22.9%).
Patients were prospectively followed up at each institution. Most patients were traditionally observed according to a protocol similar to the Japanese guidelines, 24 which recommended ultrasonography and tumor marker level measurement every 3 or 4 months, and enhanced computed tomography or magnetic resonance imaging every 6 or 12 months. The final prognosis of the registered patients was followed until confirmation of death at every survey. Although this study protocol was not submitted to the institutional review board of each institution participating in the nationwide survey, the collection and registration of the data for the patients with HCC were performed with the approval of each institution.
Statistical Analysis
The clinical characteristics of the 3 groups were compared by either the χ 2 test or the Kruskal-Wallis test. The overall and recurrence-free survival (RFS) rates after hepatectomy were calculated by the Kaplan-Meier method and were then compared by the log-rank test. Among the 11,950 patients included in this study, data on HCC recurrence were lacking in 674 patients. Therefore, the RFS rates were calculated for the remaining 11,276 patients. Nineteen clinical variables, including the hepatitis virus infection status, were evaluated by univariate analysis using the log-rank test to determine the risk factors for tumor recurrence after hepatic resection. The RFS rates were stratified according to the Child-Pugh classification and the TNM stage as defined by the LCSGJ (Table 1) . 25 The RFS curves were compared among the different histological findings of the resected nontumor liver tissues.
Continuous variables were divided into 2 groups according to the median value. Significant variables with a value of P < 0.05 by univariate analysis were subjected to a multivariate analysis using a Cox proportional hazards regression model with a backward elimination method. 26 Significance tests were 2-tailed, and a value of P < 0.05 was considered statistically significant. Bonferroni correction was applied when the RFS rates were compared between the HBV-HCC, HCV-HCC, and NBNC-HCC groups (significance threshold, P = 0.05 divided by the number of groups: P = 0.017). All statistical analyses were performed using the Statistical Analysis System software program, version 9.1.3 (SAS Inc, Cary, NC). Stage I  T1  N0  M0  Stage II  T2  N0  M0  Stage III  T3  N0  M0  Stage IVA  T4  N0  M0  T1, T2, T3, T4  N1  M0  Stage IVB  T1, T2, T3, T4  N0, N1  M1 T category is determined on the basis of the "number," "size," and "vascular and/or bile duct invasion" by the tumor. N category: N0 indicates absence of lymph node metastasis, and N1 indicates presence of lymph node metastasis. M category: M0 indicates absence of distant metastasis, and M1 indicates presence of distant metastasis.
RESULTS

Clinical Characteristics of the Study Participants
The clinical characteristics in the 3 groups are summarized in Table 2 . All of the 21 variables were significantly different among the groups. In particular, the age of the patients in the HBV-HCC group was significantly younger than that in the other 2 groups. The percentage of female patients in the HCV-HCC group was higher than that in the other 2 groups. For patients in the NBNC-HCC group, the percentage of habitual alcohol drinkers was significantly higher than that in the other 2 groups. The results of liver function tests in the HCV-HCC group were significantly worse. The incidence of a normal liver in the NBNC-HCC group (22%) was markedly higher than that in the HBV-HCC group (4%) and HCV-HCC group (2%). Conversely, the NBNC-HCC group had significantly more advanced HCC based on the tumor factors, including the tumor size and desgamma-carboxy prothrombin. In contrast, the HCV-HCC group had the smallest tumor size and the lowest percentage of portal venous invasion ( Table 2) .
Prognosis of the Patients With HCC After Hepatic Resection
The prognosis after hepatic resection is summarized in Figure 1 . The 5-year overall survival rates in the HBV-HCC, HCV-HCC, and NBNC-HCC groups were 65%, 59%, and 68%, respectively. The 5-year RFS rates were 41%, 31%, and 47%, respectively. Although the overall survival rate in the NBNC-HCC group was significantly better than that in the HBV-HCC and HCV-HCC groups, differences among the groups were relatively small (Fig. 1A ), whereas differences in the RFS rates were more distinctive (Fig. 1B) . Therefore, this study focused on the comparisons of the RFS rates among the 3 groups.
The RFS rate in the NBNC-HCC group was significantly better than that in the HBV-HCC and HCV-HCC groups. The RFS rate in the HBV-HCC group was comparable to that in the HCV-HCC group (Fig. 1B) . After stratification according to the Child-Pugh class, the RFS rate in the NBNC-HCC group was significantly better than that in the HBV-HCC and HCV-HCC groups in Child-Pugh A patients ( Fig. 2A) . No significant differences were detected among the 3 groups in the Child-Pugh B patients, possibly due to the small number of patients classified as Child-Pugh B (Fig. 2B) . When the RFS rates were stratified according to the TNM staging system (Fig. 3) , the NBNC-HCC group had a significantly better prognosis than the HBV-HCC group in the stage II, III, and IVA patients, and a significantly better prognosis than the HCV-HCC group in the stage I and II patients. When the trends of the RFS curves were compared among the different histological findings of the resected nontumor liver tissues (Fig. 4) , the curves in the HBV-HCC and NBNC-HCC groups Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. Data are shown as the median (5 percentile, 95 percentile) unless specified. * Eighty-six gram of alcohol daily for more than 10 yrs. †Questionnaire sheet requested the actual value when it was between 40 and 10,000 mAU/mL. ‡Findings of histological examination. §By the Liver Cancer Study Group of Japan. Three groups (HBV, HCV, NBNC) were classified as described in "Patients and Methods" section. DCP indicates des-gamma-carboxy prothrombin; ICGR15, indocyanine green retention rate at 15 min.
reached a plateau at 2 years after hepatic resection, but the RFS curve in the HCV-HCC group continued to decrease over time, even when patients had a normal liver. However, when patients had a cirrhotic liver, the curves in the HBV-HCC and NBNC-HCC groups decreased over time similar to the pattern observed in the HCV-HCC group. factors, whereas the remaining 16 variables, including the hepatitis virus infection status, were significant risk factors for tumor recurrence after hepatic resection. The initial multivariate model identified 11 variables as independent prognostic factors (Supplemental Table 1 , available at http://links.lww.com/SLA/A587). Consequently, the final multivariate model identified 12 variables, which included the 11 variables selected by the initial multivariate model and the indocyanine green retention rate at 15 minutes, as independent prognostic factors ( Table 4 ). The multivariate analysis revealed that the NBNC-HCC group had a significantly better RFS rate than the HBV-HCC group [hazard ratio (HR) = 1.21; 95% confidence interval (CI): 1.06-1.38, P = 0.006] or the HCV-HCC group (HR = 1.26; 95% CI: 1.13-1.41, P < 0.001). On the contrary, the HBV-HCC group had a comparable RFS rate with the HCV-HCC group (HR = 0.96; 95% CI: 0.86-1.07, P = 0.43).
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DISCUSSION
Differences in the etiologies and pathogenic mechanisms of hepatocarcinogenesis may reflect the unique clinical characteristics and prognosis in patients with HCC.
5,27-29 Therefore, this study first compared the clinicopathological backgrounds among patients with HBV-HCC, HCV-HCC, and NBNC-HCC who underwent a curative hepatic resection.
It is well known that the age at occurrence of HCC is higher in HCV-HCC than in HBV-HCC patients. [6] [7] [8] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] This study also showed that NBNC-HCC occurs at a significantly higher age (nearly 10 years older) than HBV-HCC. It is noteworthy from the viewpoint of surveillance for HCC patients that NBNC-HCC (average, 67 years; range, 51-80 years) occurred at a wider range of ages than HCV-HCC (average, 67; range, 54-78 years). Indeed, a similar tendency has been observed in previous reports. 12, 14, 18, 21 Several studies have shown that the percentage of female patients with HBV-HCC was lower Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. than that in patients with HCV-HCC 30, 31 This study also indicated that the percentage of female patients in the NBNC-HCC group was significantly lower than that in the HCV-HCC group. Because more than 95% of the patients with habitual alcohol consumption in both groups were male (data not shown), which is consistent with previous reports from Japan, 32 the higher positive percent of habitual alcohol consumption in the NBNC-HCC group may at least partially reflect the lower percentage of female patients in the NBNC-HCC group. However, the precise reasons for the sex differences among the groups remain to be determined. Histological examination revealed that the incidence of a normal liver in the NBNC-HCC group (22%) was markedly higher than Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. that in the virus-related HCC cases (2%-4%). NBNC-HCC can occur with no features of chronic liver damage, and it is often associated with NASH and metabolic syndrome. 5, 33, 34 Because fewer patients in the NBNC-HCC group received regular follow-up for the liver disease, they were generally diagnosed at a more advanced stage of HCC. 35, 36 However, in the HBV-HCC group, microscopic intrahepatic metastasis was more frequently observed compared with the NBNC-HCC group. Conversely, the HCV-HCC group had significantly less advanced tumors compared with the other 2 groups. Accordingly, HCC-related death predominated in the HBV-HCC group, whereas the liver-related death rate was higher in the HCV-HCC group. In the NBNC-HCC group, causes of death other than liverrelated and HCC-related death ("Others" in the Table 2 ) were relatively more common (22%). To our knowledge, no previous studies have compared the cause of death after hepatectomy among patients with the different hepatitis virus infection status. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Metabolic
Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
syndrome-related deaths and other organ cancer-related deaths might also have been more common in the NBNC-HCC group, although the questionnaire sheet used in this survey did not include these questions. Several studies have examined prognosis after hepatic resection for patients with NBNC-HCC. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Some showed that longterm surgical outcomes in patients with NBNC-HCC were comparable to those of patients with hepatitis virus-related HCC. 10, 19, 20 Cescon et al reported that NBNC-HCC patients had significantly better RFS rates than HBV-HCC patients. 15 Several others showed that NBNC-HCC patients had significantly better survival rates than HCV-HCC patients, but the rates were comparable with those of HBV-HCC patients. 11, 14, 17, 18 Most studies enrolled 100 or fewer patients with NBNC-HCC, with inconclusive results. This study clearly showed that the RFS rate in the NBNC-HCC group (n = 2738) was significantly better than that in the HBV-HCC and HCV-HCC groups.
The RFS curves of the NBNC-HCC group and the HBV-HCC group were distinctly different within 2 years after hepatectomy, whereas these curves were almost parallel thereafter. There are 2 types of HCC recurrence; one is "early recurrence" mainly because of intrahepatic metastasis (IM) and the other is "late recurrence" because of multicentric (MC) hepatocarcinogenesis. 37 The results of this study suggest that the risk of IM recurrence in the NBNC-HCC group was lower than that in the HBV-HCC group, whereas the risk of MC recurrence was comparable between the 2 groups. These results may explain previous findings that NBNC-HCC patients had significantly better RFS rates than HBV-HCC patients when restricting analysis to those with liver cirrhosis. 13 In this study, the RFS curves of the NBNC-HCC and HCV-HCC groups gradually broadened over time. These findings may indicate that the risk of MC recurrence in the NBNC-HCC group was lower than that in the HCV-HCC group, whereas the risk of IM recurrence was comparable between the 2 groups. This study also revealed that although the difference in the RFS rates between the HBV-HCC and HCV-HCC groups was not statistically significant, 6, 8 the patterns of recurrence (shapes of the RFS curves) between the 2 groups were substantially different (Fig. 1B) .
The study stratified the patients on the basis of the TNM stage. The NBNC-HCC group showed a significantly better prognosis than the HBV-HCC group in the more advanced tumor-stages. In contrast, the NBNC-HCC group had a significantly better prognosis than the HCV-HCC group in the earlier tumor stages. The differences in the RFS rates between the 2 groups gradually broadened over time. It seems that MC recurrence in the HCV-HCC group was more frequent than that in the NBNC-HCC group during the early tumor stages, similar to previous findings that patients with HCV-HCC had a significantly poorer prognosis than those with NBNC-HCC, when the tumor size was less than 3 cm.
11
It is important to note that differences in the overall survival rates among the 3 groups were smaller compared with those for the RFS rates as described in the previous reports. 12, 13 The precise reasons for such discordant results remain unknown. However, difference in the patterns of HCC recurrence, which also reflect the therapeutic efficacy for recurrent HCC, may explain this finding. 12 Specifically, although the HCV-HCC group had a higher risk of recurrence, this group tended to develop MC recurrence rather than IM recurrence. Because MC recurrence is associated with a greater opportunity to receive potentially curative local therapies, such as hepatectomy and radiofrequency ablation, the overall survival rate of the HCV-HCC group may have been improved. In fact, it has been shown that the overall survival rate after MC recurrence was significantly better than that after IM recurrence. 38, 39 Alternatively, metabolic syndromerelated death and other organ cancer-related death ("Others" in the Table 2 ) may account for the relatively worse overall survival in the NBNC-HCC group despite the lower risk of HCC recurrence in this group.
Twelve independent risk factors for tumor recurrence, including the hepatitis virus infection status, were identified using a Cox proportional hazards regression analysis. One previous study examined more than 100 patients with NBNC-HCC (n = 129) using a multivariate analysis to clarify the prognostic significance of the hepatitis virus infection status. However, the authors found no prognostic impact of the hepatitis virus infection status on the RFS rate after hepatectomy. 19 To our knowledge, this is the first study to demonstrate a significant prognostic advantage after hepatic resection in the NBNC-HCC group compared with the HBV-HCC and HCV-HCC groups using a multivariate analysis. Recently, Li et al 20 demonstrated that female sex was identified an independent risk factor for RFS rates in patients with NBNC-HCC. However, there were no significant sex differences in terms of the RFS rates in this study. In addition, sex was not selected as a prognostic factor in a previous nationwide study of NBNC-HCC patients. 23 One limitation of this study was the relatively short follow-up period. However, the study did observe that the specific RFS curves reflected both early recurrence and late recurrence among the 3 examined groups. In addition, because the current study was not prospectively randomized, the treatment policies were not uniform, and the effectiveness of the treatment might not be comparable among the different institutions. No information regarding the possible etiologies of NBNC-HCC, such as occult HBV infection, NASH, diabetes mellitus, or metabolic syndrome (body mass index, etc) was available because it was not included on the questionnaire sheet used in this survey. The LCSGJ may have to consider the inclusion of such information in future questionnaire surveys.
CONCLUSIONS
This large nationwide study indicated that patients with NBNC-HCC had a significantly better overall survival rate after hepatectomy than those with HBV-HCC and HCV-HCC, although the differences in the overall survival rate among the 3 groups were relatively small. Much clearer differences were observed in the RFS rates among the groups. Patients with NBNC-HCC had a significantly lower risk of HCC recurrence after hepatectomy than those with HBV-HCC and HCV-HCC, possibly owing to the fact that NBNC-HCC may be a less aggressive tumor (lower risk of IM recurrence) than HBV-HCC, although NBNC-HCC patients and HBV-HCC patients have an almost identical risk of MC recurrence. In addition, NBNC-HCC may occur less frequently (lower risk of MC recurrence) than HCV-HCC, although NBNC-HCC patients and HCV-HCC patients have a comparable risk of IM recurrence. The findings of this study suggest that it is necessary to define uniform treatment strategies for HCC patients, based not only on the tumor stage or liver functional reserve but also on hepatitis viral infection status.
